Explainable Artificial Intelligence for Drug Discovery and Development: A Comprehensive Survey
Open accessThe DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
The field of drug discovery has experienced a remarkable transformation with the advent of artificial intelligence (AI) and machine learning (ML) technologies. However, as these AI and ML models are becoming more complex, there is a growing need for transparency and interpretability of the models. Explainable Artificial Intelligence (XAI) is a novel approach that addresses this issue and provides a more interpretable understanding of the predictions made by machine learning models. In recent years, there has been an increasing interest in the application of XAI techniques to drug discovery. This review article provides a comprehensive overview of the current state-of-the-art in XAI for drug discovery, including various XAI methods, their application in drug discovery, and the challenges and limitations of XAI techniques in drug discovery. The article also covers the application of XAI in drug discovery, including target identification, compound design, and toxicity prediction. Furthermore, the article suggests potential future research directions for the application of XAI in drug discovery. This review article aims to provide a comprehensive understanding of the current state of XAI in drug discovery and its potential to transform the field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Without interpretability, these systems may generate accurate predictions but fail to provide actionable insights, thereby weakening trust and reducing the effectiveness of automated defences (Alizadehsani et al., 2024).”
From Explainable AI: enhancing decision-making in the detection of cyber threats (2026) · cites this paper as Alizadehsani et al., 2024
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 91 · Cited by 124
Research works printed but not linked: 3
- Sharma, 2022, Artificial intelligence in drug discovery (AIDD), Current Res. Inf. Pharmaceutical Sci., 16, 3
- Kunduru, 2023, Machine learning in drug discovery: A comprehensive analysis of applications, challenges, and future directions, Int. J. Orange Technol., 5, 29
- Kumar, 2022, A review on artificial intelligence and machine learning to improve cancer management and drug discovery, Int. J. Res. Appl. Sci. Biotechnol., 9, 149
Metadata
- Authors
- Alizadehsani, R., Oyelere, S. S., Hussain, S., Jagatheesaperumal, S. K., Calixto, R. R., Rahouti, M., Roshanzamir, M., & De Albuquerque, V. H. C.
- Affiliations
- Deakin University (AU)
- Luleå University of Technology (SE)
- Dibrugarh University (IN)
- Mepco Schlenk Engineering College (IN)
- Department of Teleinformatics Engineering, Federal University of Ceará, Fortaleza, Brazil
- Fordham University (US)
- Fasa University (IR)
- ORCID
- Venue
- IEEE Access
- Published
- 2024
- Volume
- 12
- Pages
- 35796-35812
- ISSN
- 2169-3536 (ISSN-L)
- OpenAlex
- W4392405811
- Cited by
- 124
- References
- 91
- Citations by year
- 2026: 58 · 2025: 49 · 2024: 15
- FWCI
- 17.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- IEEE Access (publishedVersion, cc-by)
- arXiv (Cornell University) (submittedVersion, cc-by)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- arXiv (Cornell University) (cc-by)
- Funders
- PRECISE-Luleå University of Technology (LTU-3515-2022)
- Topics
- Physical Sciences › Computer Science › Artificial Intelligence › Explainable Artificial Intelligence (XAI)
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
- Keywords
- explainable AI, drug discovery, model interpretability, target identification, compound design, toxicity prediction, drug development
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Explainable Artificial Intelligence for Drug Discovery and Development: A Comprehensive Survey. https://app.cochat.ai/papers/10.1109/access.2024.3373195
- The paper
- Alizadehsani, R., Oyelere, S. S., Hussain, S., Jagatheesaperumal, S. K., Calixto, R. R., Rahouti, M., Roshanzamir, M., & De Albuquerque, V. H. C. (2024). Explainable Artificial Intelligence for Drug Discovery and Development: A Comprehensive Survey. IEEE Access. https://doi.org/10.1109/access.2024.3373195
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.